Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Arbaclofen Placarbil (XP19986) in Subjects With Acute Back Spasms [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and tolerability of Arbaclofen Placabril (XP19986) in subjects with acute back spasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain

Drugs mentioned

• Arbaclofen Placabril (arbaclofen placarbil)

Snippet

Sponsor: XenoPort, Inc. | Conditions: Back Pain | Phase 2 | Status: COMPLETED